Zosano Pharma Corporation
ZSAN
ZSAN was delisted on the 10th of June, 2022.
31 hedge funds and large institutions have $5.92M invested in Zosano Pharma Corporation in 2020 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 6 increasing their positions, 4 reducing their positions, and 6 closing their positions.
50% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 4
33% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 6
14% more capital invested
Capital invested by funds: $5.22M → $5.92M (+$705K)
7% more funds holding
Funds holding: 29 → 31 (+2)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
+$191K |
| 2 |
BlackRock
New York
|
+$154K |
| 3 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$49.9K |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$39.2K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$29.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TI
Telemetry Investments
New York
|
-$2.05M |
| 2 |
SM
Sabby Management
Miami Beach,
Florida
|
-$114K |
| 3 |
BBVA
Banco Bilbao Vizcaya Argentaria
Madrid,
Spain
|
-$83K |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
-$33.6K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$27.2K |
ZSAN Hedge Fund Activity: Q2 2020 in Review
31 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in Zosano Pharma Corporation (ZSAN) for Q2 2020, worth a combined $5.92M — up 14% from $5.22M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new ZSAN positions and 6 closed out — a net gain of 2 holders — while 6 added to existing stakes and 4 trimmed.
The largest buyer was Geode Capital Management, adding an estimated $191K. The largest seller was Telemetry Investments, cutting an estimated $2.05M.
- 31 institutional investors held Zosano Pharma Corporation (ZSAN) as of Q2 2020, up from 29 in Q1 2020.
- Funds reported $5.92M of Zosano Pharma Corporation stock for Q2 2020, up 14% quarter-over-quarter.
- 8 funds opened new Zosano Pharma Corporation positions in Q2 2020 and 6 closed out, a net change of +2 holders.
- The largest Zosano Pharma Corporation buyer in Q2 2020 was Geode Capital Management, an estimated $191K added.
- The largest Zosano Pharma Corporation seller in Q2 2020 was Telemetry Investments, an estimated $2.05M sold.
Based on aggregated 13F filings for Q2 2020.